Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Safe Supply Announces Signing of Definitive Agreement to Acquire Drug Lab 118 (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

RMMI Corp C.RMMI

Healthcare Drug Manufacturers - Major Cannabis
"RMMI Corp is an Alberta-based company focused on the production, cultivation and sale of cannabis in various forms. The company through its wholly-owned subsidiary, Rocky Mountain Marijuana Inc is a late stage applicant under the Cannabis Act. Rocky Mountain blends science with nature using aeroponic cultivation and CO2 extraction to produce high-purity, organic-quality cannabis oils."


CSE:RMMI - Post by User

RMMI Corp > Latest press release
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Post by SigmaKappaon Aug 29, 2019 5:09am
90 Views
Post# 30078048

Latest press release

Latest press releaseNotes Heslth canada has appointed someone to review the file. Health Canada under the change in review notes 60 day max period for review. So now its a counting down days game till review. Looking like sometime october.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities